The GLA:D™ Canada Program is led by our Exercise Specialists.

GLA:D™ is a unique, seven-week, education and exercise program for people living with stiff and/or painful knees and/or hips, or those with knee and/or hip osteoarthritis. Research from GLA:D™ in Denmark shows participants report less pain, reduced use of pain killers, fewer individuals on sick leave, and being more physically active.

We’ll work with you on:

• improving your knowledge of osteoarthritis, risk factors and symptoms
• coping with the difficulties of daily activities associated with osteoarthritis
• controlling your movements and proper posture
• building muscular strength through functional exercises
• learning how to apply the exercises to everyday activities

Our Team Includes:

• your family doctor
• our Exercise Specialists

We’ll work on:

• education about osteoarthritis and the self-management of symptoms
• neuromuscular exercises that teach you how to control your movements and build muscular strength

How it works:

GLA:D™ is a seven-week, exercise-based program.

• 7-week program
• two, virtual one-hour sessions each week

Please Note: Six program sessions are available and each runs for 7 weeks:

• Session 1 – January 11 2023 – February 24 2023 (Wednesdays and Fridays from 10:30 AM to 11:30 AM)
• Session 2 – January 24 2023 – March 9 2023 (Tuesdays and Thursdays from 12:15 PM to 1:15 PM)
• Session 3 – January 23 2023 – March 10 2023 (Mondays and Fridays from 9:00 AM to 10:00 PM)
• Session 4 – March 8 2023 – April 26 2023 (Wednesdays and Fridays from 10:30 AM to 11:30 AM)
• Session 5 – March 28 2023 – May 11 2023 (Thursdays and Fridays from 12:15PM to 1:15PM)
• Session 6 – March 20 2023 – May 5 2023 (Monday and Fridays from 9:00 AM to 10:00 PM)

Who is this course for?

Patients must meet specific GLA:D™ criteria in order to join this group program.

If you have questions, please contact us at 780-410-8000 so you can speak with one of our Exercise Specialists.

About the GLA:D program by the Canadian Orthopaedic Foundation:

 

Research from the GLA:D program in Canada has shown:

• a mean 15-29% improvement in pain;
• over 30% of individuals experiencing a marked improvement in activities of daily living and sports and recreation;
• over 45% of individuals experiencing a marked improvement in quality of life;

Other outcomes include a reduction in pain intensity and reduced use of joint related pain killers.